Performing individual and population PK/PD analyses requires knowledge and experience with multiple tools to meet desired analysis outcomes within a timely manner. With Certara’s Phoenix Platform, scientist get the tools they need to efficiently perform PK/PD modeling and simulation to support drug research and development. In this webinar, our expert discusses the benefits of the solutions Phoenix WinNonlin and Phoenix NLME to streamline workflow efficiencies.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at https://www.certara.com/